3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
4
Uterine Cervical Dysplasia
3
Stomach Neoplasms
2
Neoplasms
2
Atypical Squamous Cells of the Cervix
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Squamous Intraepithelial Lesions
1
Precancerous Conditions
1
Papilloma
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Aminolevulinic Acid
2
tirbanibulin
1
ruxolitinib
1
human papillomavirus vaccine, L1 type 16, 18
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Toremifene
1
Robotic Surgical Procedures
1
Pregnancy Tests
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
Excipients
1
Colposcopy
1
Celecoxib
1
CPI-0610
1
Blood Specimen Collection
1
Biopsy
1
BF-200 ALA
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Precancerous Conditions
×
Human Papillomavirus DNA Tests
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled